US 11,806,227 B2
Sulcus implants and methods of using the same
Craig Alan Cable, II, Aliso Viejo, CA (US); Malik Y. Kahook, Denver, CO (US); Glenn R. Sussman, Aliso Viejo, CA (US); and James R. Dennewill, Aliso Viejo, CA (US)
Assigned to SpyGlass Pharma, Inc., Aliso Viejo, CA (US); and The Regents of the University of Colorado, a body coporate, Denver, CO (US)
Filed by SpyGlass Pharma, Inc., Aliso Viejo, CA (US); and The Regents of the University of Colorado, a body corporate, Denver, CO (US)
Filed on Sep. 28, 2022, as Appl. No. 17/954,631.
Application 17/954,631 is a continuation of application No. PCT/US2021/057104, filed on Oct. 28, 2021.
Claims priority of provisional application 63/108,675, filed on Nov. 2, 2020.
Claims priority of provisional application 63/106,849, filed on Oct. 28, 2020.
Claims priority of provisional application 63/106,847, filed on Oct. 28, 2020.
Prior Publication US 2023/0020167 A1, Jan. 19, 2023
Int. Cl. A61F 2/14 (2006.01); A61F 2/16 (2006.01)
CPC A61F 2/147 (2013.01) [A61F 2/1605 (2015.04); A61F 2002/169 (2015.04); A61F 2002/1682 (2015.04); A61F 2002/1689 (2013.01); A61F 2002/16901 (2015.04)] 20 Claims
OG exemplary drawing
 
1. An ocular implant configured for implantation into an eye of a subject, the ocular implant comprising:
a ring configured for implantation into the eye of the subject, the ring including an outer circumferential surface, an inner wall, and a central aperture;
a haptic connected to the ring at a haptic first end and a haptic second end;
wherein the ring comprises a hole communicating from an opening in the outer circumferential surface toward the inner wall; and
the haptic second end is slidably disposed within the hole, whereby the haptic is deformable by forces applied by tissues into which the ocular implant is implanted to force the haptic second end into the hole.